Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Elisaf

Showing results (81-90 of 151) with videos related to

Pageof 16
Sort By:
Current Pharmaceutical Design|December 27, 2005
Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemiaS S Daskalopoulou, V Tzovaras, D P Mikhailidis, et al.
American Journal of Nephrology|May 19, 2001
Severe hypomagnesemia and hypoparathyroidism in Kearns-Sayre syndromeK H Katsanos, M Elisaf, E Bairaktari, et al.
Mineral and Electrolyte Metabolism|January 1, 1994
Acid-base and electrolyte abnormalities in alcoholic patientsM Elisaf, M Merkouropoulos, E V Tsianos, et al.
American Journal of Nephrology|January 1, 1992
Hemorrhagic fever with renal syndrome in an endemic area of GreeceK C Siamopoulos, M Elisaf, A Antoniadis, et al.
Current Vascular Pharmacology|October 18, 2016
Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption InhibitionV Tsimihodimos, T D Filippatos, S Filippas-Ntekouan, et al.
Human Mutation|September 12, 2000
Segregation of a novel LDLR gene mutation (I430T) with familial hypercholesterolaemia in a Greek pedigreeG Miltiadous, M Elisaf, S Xenophontos, et al.
Clinical Nephrology|July 1, 1991
Treatment of nephrotic hyperlipidemia with lovastatinM Elisaf, M Dardamanis, M Pappas, et al.
Current Medical Research and Opinion|June 18, 2004
Uric acid levels and vascular diseaseS S Daskalopoulou, V G Athyros, M Elisaf, et al.
Current Pharmaceutical Design|July 20, 2005
The predictive value of lipid markers in vascular diseaseH J Milionis, S S Daskalopoulou, M Elisaf, et al.
Journal of Human Hypertension|December 1, 1993
Atherosclerotic risk factors in female students of northwestern GreeceM Elisaf, N Papanikolaou, G Letzaris, et al.
Pageof 16

Showing results (81-90 of 151) with videos related to

Sort By:
Pageof 16
Current Pharmaceutical Design|December 27, 2005
Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemiaS S Daskalopoulou, V Tzovaras, D P Mikhailidis, et al.
American Journal of Nephrology|May 19, 2001
Severe hypomagnesemia and hypoparathyroidism in Kearns-Sayre syndromeK H Katsanos, M Elisaf, E Bairaktari, et al.
Mineral and Electrolyte Metabolism|January 1, 1994
Acid-base and electrolyte abnormalities in alcoholic patientsM Elisaf, M Merkouropoulos, E V Tsianos, et al.
American Journal of Nephrology|January 1, 1992
Hemorrhagic fever with renal syndrome in an endemic area of GreeceK C Siamopoulos, M Elisaf, A Antoniadis, et al.
Current Vascular Pharmacology|October 18, 2016
Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption InhibitionV Tsimihodimos, T D Filippatos, S Filippas-Ntekouan, et al.
Human Mutation|September 12, 2000
Segregation of a novel LDLR gene mutation (I430T) with familial hypercholesterolaemia in a Greek pedigreeG Miltiadous, M Elisaf, S Xenophontos, et al.
Clinical Nephrology|July 1, 1991
Treatment of nephrotic hyperlipidemia with lovastatinM Elisaf, M Dardamanis, M Pappas, et al.
Current Medical Research and Opinion|June 18, 2004
Uric acid levels and vascular diseaseS S Daskalopoulou, V G Athyros, M Elisaf, et al.
Current Pharmaceutical Design|July 20, 2005
The predictive value of lipid markers in vascular diseaseH J Milionis, S S Daskalopoulou, M Elisaf, et al.
Journal of Human Hypertension|December 1, 1993
Atherosclerotic risk factors in female students of northwestern GreeceM Elisaf, N Papanikolaou, G Letzaris, et al.
Pageof 16